IP Library Granted Patent US 8,580,321
Granted Patent B2
US 8,580,321 · App. 12/369,704 · Granted Nov 12, 2013

Method for reducing the effects of chemotherapy using flagellin related polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,321
App. No.
12/369,704
Granted
Nov 12, 2013
Kind
B2
Abstract

The use of flagellin and flagellin related polypeptides for reducing cancer treatment side effects in mammals is described.

Claims (6)

1. A method of reducing a side effect of a cancer treatment in a mammal, comprising administering to a mammal in need thereof a composition comprising a therapeutically effective amount of flagellin wherein the cancer treatment is cisplatinum.

2. The method of claim 1 , wherein the side effect is selected from the group consisting of: myelosuppression, renal toxicity, weight loss, pain, nausea, vomiting, diarrhea, constipation, anemia, malnutrition, hair loss, numbness, changes in tastes, loss of appetite, thinned or brittle hair, mouth sores, memory loss, hemorrhage, cardiotoxicity, hepatotoxicity, ototoxicity, and post-chemotherapy cognitive impairment.

3. The method of claim 1 , wherein the cancer treatment further comprises radiation therapy.

4. The method of claim 2 , wherein the side effect is selected from the group consisting of: myelosuppression, renal toxicity, and weight loss.

5. The method of any one of claims 1 , 2 , 3 , and 4 , wherein the mammal is a human.

6. The method of any one of claims 1 , 2 , 3 , 4 , and 5 , wherein cisplatinum is administered at 50-270 mg/m 2 /day.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2012
From: CLEVELAND BIOLABS, INC.
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 028994/0456 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2009
From: BURDELYA, LYUDMILA
To: CLEVELAND CLINIC FOUNDATION
Reel/Frame 022831/0955 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2009
From: GUDKOV, ANDREI V.; KRIVOKRYSENKO, VADIM
To: CLEVELAND BIOLABS, INC.
Reel/Frame 022832/0029 →